   Prim^+^/Met^+^   000   00             000 (00-NA)                                     \<0.000 [\*](#tfn_000){ref-type="table-fn"}   00 (00-NA)                                      \<0.000[\*](#tfn_000){ref-type="table-fn"}   Prim^−^/Met^+^                            00               00    000 (00-000)   0.000 [\*\*](#tfn_000){ref-type="table-fn"}     00 (00-00)                                    0.000 [\*\*](#tfn_000){ref-type="table-fn"}        Prim^+^/Met^−^                            000              00    00 (00-000)    \<0.000 [\*\*](#tfn_000){ref-type="table-fn"}   00 (00-00)                                    0.000 [\*\*](#tfn_000){ref-type="table-fn"}        Prim^−^/Met^−^                            000              00    00 (00-000)    \<0.000 [\*\*](#tfn_000){ref-type="table-fn"}   00 (00-00)                                    \<0.000 [\*\*](#tfn_000){ref-type="table-fn"}     Abbreviations: ER, estrogen receptor; PR, progesterone receptor; Prim, receptor status of the primary lesion; Met, receptor status of the metastatic lesion; N